Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram Maintenance for Major Depression Following Mild TBI
NCT00162916Phase 4Unknown
- Sponsor
- Ontario Neurotrauma Foundation
- Start
- May 2005
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Placebo with citalopram (2 arms). Primary endpoint: Recurrence of Major Depression at 40 weeks. Status: unknown.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00162916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162916.